Welcome to our dedicated page for Cronos Group news (Ticker: CRON), a resource for investors and traders seeking the latest updates and insights on Cronos Group stock.
Cronos Group Inc. (CRON) generates frequent news as a cannabinoid-focused company active in medical and adult-use cannabis markets across Canada, Israel and multiple international regions. Company updates often highlight brand performance, international expansion, product launches and financial results, offering investors and industry observers insight into how Cronos executes its global cannabis strategy.
News coverage for Cronos commonly includes quarterly earnings releases, where the company reports net revenue, gross profit, adjusted EBITDA and commentary on business performance by geography and brand. These releases also describe developments such as the consolidation and expansion of cultivation operations at Cronos Growing Company Inc. (Cronos GrowCo) and the company’s cash and short-term investment position.
Another major category of Cronos news involves brand and product announcements. Recent press releases describe new SOURZ by Spinach® Fully Blasted multipack gummies, seasonal Spinach® Caramel Green Apple gummies and vapes, and Lord Jones® Live Resin Fusions™ pre-rolls in Canada. These updates show how Cronos uses its Spinach® and Lord Jones® brands to introduce new formats and flavor profiles in the Canadian adult-use market.
Cronos also issues news on its international footprint and strategic transactions. Examples include the expansion of PEACE NATURALS® medical cannabis distribution in Switzerland through a partnership with Dascoli Pharma AG, and a definitive agreement for a Cronos subsidiary to acquire CanAdelaar B.V., a licensed producer in the Netherlands’ adult-use cannabis pilot program. In addition, the company has announced a junior secured convertible loan investment in High Tide Inc., a cannabis retailer, outlining the terms of that financing.
Investors and followers of CRON can use this news feed to review earnings announcements, track new product introductions under Spinach®, PEACE NATURALS® and Lord Jones®, and monitor strategic moves such as international partnerships, acquisitions and capital investments.
Cronos Group (NASDAQ: CRON) reported record net revenue of $44.5M in Q4 2025 and $146.6M for FY 2025, up 47% and 25% year-over-year respectively. Adjusted EBITDA improved to $10.1M for the year. The company holds approximately $832M in cash and short-term investments and announced a €57.5M (~$67M) agreement to acquire CanAdelaar, subject to Netherlands regulatory clearances expected in H1 2026.
Cronos (NASDAQ: CRON) launched Spinach PUFFERZ™, a 1g all‑in‑one vape infused with liquid diamonds and delivering 98.1% THC. The palm‑style device features a squishy exterior, dual ceramic coil, boost button and battery meter. Three flavors debut now in Alberta, British Columbia and Ontario; national availability by April 2026.
The product targets modern cannabis consumers seeking design, flavor and convenience under the Spinach brand.
Cronos (NASDAQ: CRON; TSX: CRON) will hold its 2025 fourth quarter and full-year earnings conference call on Thursday, February 26, 2026 at 8:30 a.m. ET.
Senior management will discuss financial results and take investor questions after prepared remarks. Registration and webcast access are available via the company’s investor website, and the webcast will be archived for replay.
Cronos Group (NASDAQ: CRON) launched its premium Lord Jones cannabis brand in Israel on February 2, 2026, introducing five indoor-grown flower strains to the Israeli medical market.
The rollout emphasizes small-batch indoor cultivation, cold-cure processing, hand trimming and glass jar packaging, and will expand with special editions and limited-run products.
Cronos (NASDAQ: CRON) announced on December 9, 2025 that a wholly‑owned subsidiary signed a definitive agreement to acquire CanAdelaar B.V., the largest company in the Netherlands’ adult‑use cannabis pilot (Wietexperiment).
Up‑front consideration is €57.5 million (US$67.0 million), roughly 1.4x LTM revenue and 2.4x LTM EBITDA, with an additional cash earnout equal to 0.5x normalized EBITDA in 2026 and 2027. Cronos said the deal will deliver a #1 market share in the Netherlands and support its borderless product strategy using existing genetics, R&D, and product development investments.
Cronos (NASDAQ: CRON) launched Lord Jones Live Resin Fusions™ pre-rolls in Canada on November 25, 2025, expanding the Lord Jones premium cannabis portfolio.
Each 0.5g pre-roll pairs single-sourced dried flower with terpene-rich pure live resin caviar, targets 42%+ THC potency, and includes a reusable ceramic tip for a cooler smoke. New strains available at select Canadian retailers are Durban Kush x Citrus Sap, Hell Fire OG x Cali Gas, and Sour Diesel x Orange Velvet. More details and the full collection are available at lordjones.ca.
Cronos Group (NASDAQ: CRON) reported Q3 2025 results with net revenue of $36.3M, up 6% year‑over‑year and 9% sequentially, driven by record sales in Israel where PEACE NATURALS is the top brand. Gross profit rose to $18.3M and Adjusted EBITDA was positive $5.7M. The company ended the quarter with an industry‑leading liquidity position of $824M in cash and short‑term investments. Spinach retained the #2 brand ranking in Canada and Lord Jones and PEACE NATURALS showed strong category positions. Cronos GrowCo expansion completed with new flower capacity coming online in Fall 2025; international ex‑Israel shipments were modest this quarter due to timing.
Cronos (NASDAQ: CRON) is reintroducing its limited-edition SOURZ by Spinach Caramel Green Apple flavor for the Fall and Halloween 2025 season. The rollout returns the original Caramel Green Apple 5-pack gummies and adds two new fall exclusives: a Fully Blasted Caramel Green Apple 10mg THC gummy and a Spinach Sweet Green Apple 1g Sativa vape infused with liquid diamonds.
The flavor first launched in Fall 2024; the seasonal products are available now across Canada. For product details and store availability, the company directs consumers to the Spinach website.
Cronos Group (NASDAQ: CRON) will hold its 2025 third quarter earnings conference call on Thursday, November 6, 2025 at 8:30 a.m. ET. Senior management will discuss the company’s financial results and take questions after prepared remarks.
Participants must register to attend the call or webcast at https://ir.thecronosgroup.com/events-presentations. The company recommends dialing in 15 minutes early to avoid delays. A webcast replay will be archived on the company website.
Cronos (NASDAQ: CRON) announced on October 9, 2025 that its SOURZ by Spinach Fully Blasted gummies will be sold in new multipack formats featuring liquid diamond‑infused gummies.
Products will launch in 5‑pack (5 x 10mg THC) and 10‑pack (10 x 10mg THC; one 10mg THC|10mg CBD SKU) configurations across five core flavors and will be available now in Alberta, British Columbia, Manitoba, Newfoundland, Nova Scotia, Ontario, Prince Edward Island, and Saskatchewan.
Management highlighted that SOURZ by Spinach holds just over 20% market share and has ranked as the #1 edible in Canada since September 2024, positioning the multipacks as a convenience and value play for existing customers.